Assembly Biosciences, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2021
Total Assets: $191.1M
Liabilities Breakdown FY2021
Total Liabilities: $22.1M
Asset Breakdown
Total Assets: $191.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $45.6M | 23.9% |
| Accounts Receivable | $336.0K | 0.2% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.1M | 0.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $144.0M | 75.3% |
Liabilities Breakdown
Total Liabilities: $22.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.7M | 12.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $19.5M | 88.0% |